 |
|
|
|
|
|
General Clinical Research Center
Room MN578
University of Kentucky Medical Center
800 Rose Street
Lexington, KY 40536-0298
Grant No. M01 RR02602
URL: www.mc.uky.edu/gcrc/
|
For information
about this GCRC and how to access its resources, please
contact:
Administrative Director
Nancy E. Kukulinsky, Ph.D.
859-323-7939; Fax: 859-257-9560
E-mail:
nkuku2@uky.edu
|
|
|
|
Program Director
Hartmut H. Malluche, M.D.
859-323-5049; Fax: 859-257-9560
E-mail:
hhmall@uky.edu
Principal Investigator
Jay A. Perman, M.D.
859-323-6582; Fax: 859-323-2039
E-mail:
japerm2@email.uky.edu
Associate Program Director
Steven Shedlofsky, M.D.
859-323-5575; Fax: 859-323-1020
E-mail:
shedlof@uky.edu
Assistant Program Director
Peter Sawaya, M.D.
859-323-5049 x224; Fax: 859-323-1020
E-mail:
besawa0@pop.uky.edu
Research Subject Advocate
Marie Claude Faugere, M.D.
859-323-5049 x230; Fax: 859-323-1020
E-mail:
mcfaug0@pop.uky.edu
Nurse Manager
Vince Cecil, R.N., B.S.N.
859-323-6481; Fax: 859-257-9560
E-mail:
tvceci2@uky.edu
|
Nutrition Research Manager
Karen Kitzman, R.D.
859-257-2731; Fax: 859-257-9560
E-mail:
karens2@uky.edu
Biostatistician
Richard Kryscio, Ph.D.
859-257-4064; Fax: 859-323-1973
E-mail:
kryscio@uky.edu
Core Laboratory Director
John Williams, Ph.D.
859-323-5049 x231; Fax: 859-323-0232
E-mail:
jpwill2@pop.uky.edu
Exercise Physiology
Jody Clasey, Ph.D.
859-257-8055; Fax: 859-323-1090
E-mail:
jlclas0@uky.edu
Informatics Manager
Eva Li, M.S.
859-257-4976; Fax: 859-257-9560
E-mail:
evali@uky.edu
|
|
|
Aging: Etiologies and new therapies for Alzheimer's
disease.
Behavioral Science: Endogenous opioids, stress and
hypertension; etiologies for drug-seeking behavior.
Cardiology and Biomedical Engineering: Mechanisms and novel
therapies for congestive heart failure; mechanisms for
syncope.
Gastroenterology: Cytokines and alcoholic hepatitis;
cytokines and cytochrome P450 regulation; oxidative
stress-sensitive transcription factors (e.g., NFkB) and
gastrointestinal diseases; novel therapies for
pancreatitis.
Immunology and Transplantation: Novel therapies for
transplant rejection including specific monoclonal
antibodies.
Infectious Diseases: New therapies for AIDS,
alcohol-AIDS interactions.
Neurology: Etiology and therapy for amyotrophic
lateral sclerosis; mechanisms of altered metabolism
following brain injury; nutritional and metabolic response
to head injury and growth factor therapy following head injury.
Nutrition: Nutrition in trauma and transplantation
patients, alcoholics, HIV patients, and eating disorder
subjects.
Obstetrics and Gynecology: Postmenopausal
osteoporosis.
Oncology: Novel "vaccine therapy" for
specific cancers (melanoma, colon cancer); circadian rhythm and
cancer chemotherapy.
Pharmacy: Targeted drug delivery; drug metabolism
and drug delivery in breast milk.
Psychiatry: Nutritional and metabolic abnormalities
in and therapies for eating disorders.
Pulmonary Disorders: Mechanisms and treatment of
adult respiratory distress syndrome.
Renal Diseases: Metabolic bone disease.
|
 |
|
